News

Business Wire1y
Oxular Doses First Patients in OXEYE Phase 2 Clinical Trial of Suprachoroidal OXU-001 as a Long-Acting Treatment for Diabetic Macular Edema - Business Wire
OXU-001 is dexamethasone formulated in a novel biodegradable drug preparation known as Oxuspheres™. OXU-001 is optimized for delivery to the posterior suprachoroidal space of the eye via ...
Daily Voice on MSN6d
Aflac May Have Exposed Social Security Numbers, Other Info
Aflac has confirmed a cybersecurity breach that may have compromised sensitive customer information. The company is the ...
Business Wire2y
Oxular Limited Announces Acceptance of IND for Suprachoroidal OXU-001 for the Treatment of Diabetic Macular Edema - Business Wire
OXU-001 represents potential best-in-class treatment for DME with just one, targeted administration per year. Initiation of OXEYE Phase 2 clinical trial of OXU-001 in DME patients on-track for ...